Neuromuscular Training Decreased Incidence of Chemo-Induced Peripheral Neuropathy Incidence significantly reduced with two types of exercises versus usual care Jul 01, 2024
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials News, features, and commentary about cancer-related issues Jun 28, 2024
Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria No difference in adverse events, clinical benefit, OS for patients with or without waivers Jun 27, 2024
Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complications Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4 Jun 27, 2024 video
What's a Normal PSA Value for Transgender Women on Estrogen Therapy? Study suggests threshold is too high to identify risk of prostate cancer in this population Jun 26, 2024
Oncology Drug Shortages Persist, but Continue to Evolve Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer Adding the mTOR inhibitor didn't improve EFS in intermediate-risk rhabdomyosarcoma Jun 25, 2024
Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury Case reports may not be as reliable, researchers say Jun 25, 2024
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients Jun 25, 2024 video
Acupuncture Reduced Hot Flashes Related to Endocrine Therapy for Breast Cancer 64% of women reported at least a 50% reduction in hot flash frequency and severity Jun 24, 2024
Subcutaneous C5 Inhibitor Approved for PNH Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
Treating Advanced Breast Cancer After Progression on CDK4/6 Inhibitors Results from postMONARCH offer one path Jun 24, 2024 video
Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverage Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however Jun 24, 2024
Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancer KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer Clinical landscape has shifted away from traditional risks for H&N cancer to HPV predominance Jun 21, 2024
ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types Phase II study found brigatinib exceeded historical control by shrinking 10% of targeted tumors Jun 21, 2024
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer News, features, and commentary about cancer-related issues Jun 21, 2024
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response Jun 20, 2024
Glofitamab Regimen Improves Survival in DLBCL Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
Using MRD Status to Deescalate Multiple Myeloma Therapy Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer New indications for pembrolizumab and durvalumab in advanced disease Jun 17, 2024
New Standard of Care in High-Risk Acute Promyelocytic Leukemia? All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
I Tried to Protect My Mother From Dying in Pain. The Law Robbed Her of That Dignity. It's time to clear the roadblocks to Medical Aid in Dying in the U.S. Jun 16, 2024
Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
Atezolizumab Consolidation Impresses in High-Risk DLBCL Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
Kate Middleton Gives Cancer Update Princess of Wales says she's making "good progress" in treatment Jun 14, 2024
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
Early Menopause Tied to Higher Risk of Respiratory Mortality Greatest risk observed for women with bilateral oophorectomy Jun 13, 2024
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? News, features, and commentary about cancer-related issues Jun 13, 2024
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
Tanning Salons Are Overdue for a Regulatory Burn In the meantime, don't forget to educate patients on the risks Jun 13, 2024
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer No difference in PFS, median OS favored control group Jun 12, 2024
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
Middle-Age Man Presents With Necrotizing Mass on Nose Rare condition can be deadly without early diagnosis and treatment Jun 10, 2024